JP2025505410A5 - - Google Patents
Info
- Publication number
- JP2025505410A5 JP2025505410A5 JP2024544733A JP2024544733A JP2025505410A5 JP 2025505410 A5 JP2025505410 A5 JP 2025505410A5 JP 2024544733 A JP2024544733 A JP 2024544733A JP 2024544733 A JP2024544733 A JP 2024544733A JP 2025505410 A5 JP2025505410 A5 JP 2025505410A5
- Authority
- JP
- Japan
- Prior art keywords
- cytometry
- event
- platform
- machine learning
- events
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263304990P | 2022-01-31 | 2022-01-31 | |
| US63/304,990 | 2022-01-31 | ||
| PCT/US2023/012003 WO2023147177A1 (en) | 2022-01-31 | 2023-01-31 | Machine learning techniques for cytometry |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505410A JP2025505410A (ja) | 2025-02-26 |
| JP2025505410A5 true JP2025505410A5 (https=) | 2026-01-26 |
Family
ID=85410103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544733A Pending JP2025505410A (ja) | 2022-01-31 | 2023-01-31 | サイトメトリーのための機械学習法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230245479A1 (https=) |
| EP (1) | EP4473288B1 (https=) |
| JP (1) | JP2025505410A (https=) |
| AU (1) | AU2023213817A1 (https=) |
| CA (1) | CA3249858A1 (https=) |
| WO (1) | WO2023147177A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240177803A1 (en) | 2022-11-17 | 2024-05-30 | Bostongene Corporation | Comprehensive immunoprofiling of peripheral blood |
| EP4695425A1 (en) | 2023-04-13 | 2026-02-18 | BostonGene Corporation | Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration |
| WO2025072692A1 (en) * | 2023-09-29 | 2025-04-03 | Dana-Farber Cancer Institute, Inc. | Compositions for treating hematological conditions and methods of making and using the same |
| WO2025096308A1 (en) * | 2023-10-30 | 2025-05-08 | Beckman Coulter, Inc. | Classification of events in flow cytometry data |
| WO2025258375A1 (ja) * | 2024-06-12 | 2025-12-18 | ソニーグループ株式会社 | 情報処理方法及び情報処理システム |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4777127A (en) | 1985-09-30 | 1988-10-11 | Labsystems Oy | Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus |
| GB8702816D0 (en) | 1987-02-07 | 1987-03-11 | Al Sumidaie A M K | Obtaining retrovirus-containing fraction |
| US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
| US5422120A (en) | 1988-05-30 | 1995-06-06 | Depotech Corporation | Heterovesicular liposomes |
| AP129A (en) | 1988-06-03 | 1991-04-17 | Smithkline Biologicals S A | Expression of retrovirus gag protein eukaryotic cells |
| WO1990007936A1 (en) | 1989-01-23 | 1990-07-26 | Chiron Corporation | Recombinant therapies for infection and hyperproliferative disorders |
| CA2489769A1 (en) | 1989-03-21 | 1990-10-04 | Philip L. Felgner | Expression of exogenous polynucleotide sequences in a vertebrate |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| AU648261B2 (en) | 1989-08-18 | 1994-04-21 | Novartis Vaccines And Diagnostics, Inc. | Recombinant retroviruses delivering vector constructs to target cells |
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| ZA911974B (en) | 1990-03-21 | 1994-08-22 | Res Dev Foundation | Heterovesicular liposomes |
| DE69233013T2 (de) | 1991-08-20 | 2004-03-04 | The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
| WO1993010218A1 (en) | 1991-11-14 | 1993-05-27 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Vectors including foreign genes and negative selective markers |
| GB9125623D0 (en) | 1991-12-02 | 1992-01-29 | Dynal As | Cell modification |
| FR2688514A1 (fr) | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
| EP0650370A4 (en) | 1992-06-08 | 1995-11-22 | Univ California | METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES. |
| CA2137361A1 (en) | 1992-06-10 | 1993-12-23 | W. French Anderson | Vector particles resistant to inactivation by human serum |
| GB2269175A (en) | 1992-07-31 | 1994-02-02 | Imperial College | Retroviral vectors |
| EP1024198A3 (en) | 1992-12-03 | 2002-05-29 | Genzyme Corporation | Pseudo-adenoviral vectors for the gene therapy of haemophiliae |
| US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| PT695169E (pt) | 1993-04-22 | 2003-04-30 | Skyepharma Inc | Lipossomas multivesiculares de ciclodextrina encapsulando compostos farmacologicos e metodos para a sua utilizacao |
| EP0705344B8 (en) | 1993-06-24 | 2006-05-10 | Advec Inc. | Adenovirus vectors for gene therapy |
| DK0814154T3 (da) | 1993-09-15 | 2009-08-31 | Novartis Vaccines & Diagnostic | Rekombinante alfavirusvektorer |
| US6015686A (en) | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| AU687117B2 (en) | 1993-10-25 | 1998-02-19 | Canji, Inc. | Recombinant adenoviral vector and methods of use |
| AU686277B2 (en) | 1993-11-16 | 1998-02-05 | Pacira Pharmaceuticals, Inc. | Vesicles with controlled release of actives |
| DE69535669T2 (de) | 1994-05-09 | 2008-12-04 | Oxford Biomedica (Uk) Ltd. | Retrovirale vektoren mit verminderter rekombinationsrate |
| AU4594996A (en) | 1994-11-30 | 1996-06-19 | Chiron Viagene, Inc. | Recombinant alphavirus vectors |
| WO1997042338A1 (en) | 1996-05-06 | 1997-11-13 | Chiron Corporation | Crossless retroviral vectors |
| WO2000053211A2 (en) | 1999-03-09 | 2000-09-14 | University Of Southern California | Method of promoting myocyte proliferation and myocardial tissue repair |
| CN101981446B (zh) * | 2008-02-08 | 2016-03-09 | 医疗探索公司 | 用于使用支持向量机分析流式细胞术数据的方法和系统 |
| AU2015360448A1 (en) * | 2014-12-10 | 2017-06-29 | Neogenomics Laboratories, Inc. | Automated flow cytometry analysis method and system |
| WO2020081582A1 (en) * | 2018-10-16 | 2020-04-23 | Anixa Diagnostics Corporation | Methods of diagnosing cancer using multiple artificial neural networks to analyze flow cytometry data |
| US20210356379A1 (en) * | 2018-10-31 | 2021-11-18 | Takeda Pharmaceutical Company Limited | Quantitative flow cytometry |
| JP7381003B2 (ja) * | 2019-04-26 | 2023-11-15 | 学校法人順天堂 | 疾患解析を支援する方法、装置、及びコンピュータプログラム、並びにコンピュータアルゴリズムを訓練する方法、装置、及びプログラム |
| EP4172591A4 (en) * | 2020-06-03 | 2024-05-29 | Case Western Reserve University | Classification of blood cells |
-
2023
- 2023-01-31 CA CA3249858A patent/CA3249858A1/en active Pending
- 2023-01-31 AU AU2023213817A patent/AU2023213817A1/en active Pending
- 2023-01-31 EP EP23708082.5A patent/EP4473288B1/en active Active
- 2023-01-31 WO PCT/US2023/012003 patent/WO2023147177A1/en not_active Ceased
- 2023-01-31 JP JP2024544733A patent/JP2025505410A/ja active Pending
- 2023-01-31 US US18/104,050 patent/US20230245479A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025505410A5 (https=) | ||
| Sjøberg et al. | Questioning software maintenance metrics: a comparative case study | |
| Sasidharan et al. | Application of propensity scores and potential outcomes to estimate effectiveness of traffic safety countermeasures: Exploratory analysis using intersection lighting data | |
| Pikula et al. | White-nose syndrome pathology grading in Nearctic and Palearctic bats | |
| Karatzas et al. | Development of deep learning models for predicting the effects of exposure to engineered nanomaterials on Daphnia magna | |
| DE112011103687B4 (de) | Zentromerdetektor und Methode zur Bestimmung der Strahlenbelastung durch Chromosomabnormalitäten | |
| JP2022513316A5 (https=) | ||
| CN109119133A (zh) | 基于多标记特征选择及分类的中医临床大数据存储方法 | |
| JP2020534622A5 (https=) | ||
| Linden et al. | Using ODA in the evaluation of randomized controlled trials | |
| Sakar et al. | Using of factor analysis scores in multiple linear regression model for prediction of kernel weight in Ankara walnuts | |
| JP2019525133A5 (https=) | ||
| US10303923B1 (en) | Quantitation of NETosis using image analysis | |
| Phu et al. | Multiple (frontloaded) visual field tests increase identification of very slow mean deviation progression in glaucoma | |
| Ovacik et al. | Pathway modeling of microarray data: a case study of pathway activity changes in the testis following in utero exposure to dibutyl phthalate (DBP) | |
| Romme et al. | Analysis and visualization of the effect of multiple sclerosis on biological brain age | |
| Wong et al. | Learning from project monitoring feedback: A case of optimizing behavior of contractors | |
| Budak | Prediction of Water Quality’s pH value using Random Forest and LightGBM Algorithms | |
| Kirchweger et al. | Improving farm competitiveness through farm-investment support: a propensity score matching approach | |
| CN118197554A (zh) | 用于重度抑郁症患者tms干预的疗效自动评估方法及系统 | |
| Jovani et al. | Group size versus individual group size frequency distributions: a nontrivial distinction | |
| CN118197606A (zh) | 一种基于肺子区域分割的放射性肺炎评估方法和系统 | |
| Zhang et al. | Radio-iBAG: Radiomics-based integrative Bayesian analysis of multiplatform genomic data | |
| Garrido et al. | Analysis of the Flemish Cap cod fishery: monitoring of the consequences of the management decisions | |
| Dutz et al. | Modelling for radiation treatment outcome |